Apollo Hospitals Q3 Results: Profit rises 35% YoY to Rs 502 crore; Rs 10 per share dividend declared

Leading hospitals chain Apollo Hospitals reported 35% year-on-year (YoY) growth in its consolidated net profit at Rs 502 crore in the third quarter. The Board has also declared an interim dividend of Rs 10 per share for the financial year 2026.

The record date for the same has been fixed as February 16 and it will be paid on or before February 27.

Revenue for the third quarter came in at Rs 6,477 crore as against Rs 5,527 crore in same quarter of last year, showing a growth of 17%.

EBITDA, meanwhile, increased to Rs 965 crore in the reporting quarter from Rs 762 crore in Q3FY25. This is after Apollo 24/7 cost of Rs 124 crore in the quarter.

The healthcare services business posted revenue of Rs 3,183 crore in Q3FY26, compared with Rs 2,785 crore in the year-ago quarter, registering a growth of 14% YoY. EBITDA for the segment rose 18% to Rs 790 crore, with margins improving to 24.8%.

Profit after tax from the business stood at Rs 422 crore, up 21% from Rs 348 crore a year earlier, supported by higher occupancy levels, better case mix and cost efficiencies.
Apollo Health and Lifestyle, which houses the company’s clinics, diagnostics and day-care formats, also reported healthy growth. Revenue from the segment increased 20% YoY to Rs 467 crore in Q3FY26, compared with Rs 390 crore in the corresponding quarter last year. EBITDA jumped 39% to Rs 48 crore from Rs 34 crore, with margins expanding to 10.2%. The segment reported a net loss of Rs 6 crore during the quarter, narrowing from a loss of Rs 8 crore in Q3FY25, reflecting improving scale and operating leverage.

Apollo HealthCo, which includes the company’s pharmacy distribution, digital healthcare and consumer health platforms, delivered a sharp improvement in profitability. Revenue rose 20% YoY to Rs 2,827 crore in Q3FY26. EBITDA more than doubled to Rs 128 crore from Rs 57 crore in Q3FY25, with margins improving to 4.5%. Profit after tax for the segment increased to Rs 87 crore, compared with Rs 32 crore in the same quarter last year.

“This quarter, sustained investments in advanced clinical capability translated into meaningful progress across key specialties from Apollo OMR completing 150 robotic joint replacement surgeries in its first 150 days, to the expansion of our stroke care network in Chennai with nine advanced stroke labs, strengthening rapidaccess care and outcomes,” said Dr Prathap C Reddy, Chairman, Apollo Hospitals.

Apollo said it will work closely with policymakers and state partners to strengthen international patient pathways, expand high-acuity capacity, and ensure seamless coordination across pre-travel evaluation, clinical care, and post-discharge follow-up.